Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
3.320
-2.880 (-46.45%)
At close: Oct 27, 2025, 4:00 PM EDT
3.270
-0.050 (-1.51%)
After-hours: Oct 27, 2025, 6:46 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $63.57 million as of October 27, 2025. Its market cap has decreased by -21.01% in one year.
Market Cap
63.57M
Enterprise Value
51.69M
1-Year Change
-21.01%
Ranking
Category
Stock Price
$3.32
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $63.57M, a decrease of -69.55%. That is a compound annual growth rate of -26.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 118.71M | 49.20% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |